FIA
PHVS icon

FNY Investment Advisers’s Pharvaris PHVS Stock Holding History

FNY Investment Advisers’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-880
Closed -$9K – 681
2022
Q4 		$9K Buy
+880
New +$4.63K 0.01% 317

Other funds holding PHVS

FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

FNY Investment Advisers's PHVS Position: Q1 2023 in Review

FNY Investment Advisers sold out of Pharvaris (PHVS) in Q1 2023, closing a stake of 880 shares — an estimated $9K sold.

FNY Investment Advisers first reported a position in PHVS in Q4 2022 and held it in 1 quarter. The position peaked at $9K in Q4 2022. 21 funds tracked by Wall St. Rank hold PHVS as of Q1 2023.

  • FNY Investment Advisers reported no remaining Pharvaris position as of Q1 2023 after selling out during the quarter.
  • FNY Investment Advisers sold 880 Pharvaris shares in Q1 2023, an estimated $9K.
  • FNY Investment Advisers first reported a position in Pharvaris in Q4 2022 and held it in 1 quarter.
  • FNY Investment Advisers's Pharvaris position peaked at $9K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held Pharvaris as of Q1 2023.

Based on FNY Investment Advisers's 13F filing for Q1 2023, filed 12 Apr 2023.